ArticleTranslational cancer research2025
A novel machine learning-based predictive model for gastric cancer.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastric cancer (GC) is a prevalent malignancy worldwide, necessitating the discovery of biomarkers for early diagnosis and progression prediction. This study aimed to identify core genes associated with GC. Methods: This study integrated data from the Gene Expression Omnibus (GEO) database, encompassing multiple datasets. Differential expression and enrichment analyses identified genes linked to GC. Using machine learning algorithms-least absolute shrinkage and selection operator (LASSO) regression, support vector machine (SVM), and random forest (RF)-predictive models were constructed, with the optimal one selected for further investigation. The SHapley Additive exPlanations (SHAP) method was applied to assess the contribution of core genes. Additionally, gene set enrichment analysis (GSEA) and immune cell infiltration analysis were conducted to explore related molecular mechanisms. Results: This study identified 130 differentially expressed genes (DEGs), which exhibited enrichment in functions and pathways potentially linked to GC. Through the collective application of multiple machine learning methods, 4 key genes associated with GC ( Conclusions: This study provided potential biomarkers and contributed to the theoretical basis for GC prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.